Horizon Pharmaceuticals

West Palm Beach, United States Founded: 2008 • Age: 18 yrs
Blow fill Seal Horizon Pharmaceuticals packaging BFS aseptic steril bottles

About Horizon Pharmaceuticals

Horizon Pharmaceuticals is a Healthcare company based in West Palm Beach (United States) founded in 2008. Blow fill Seal Horizon Pharmaceuticals packaging BFS aseptic steril bottles. Horizon Pharmaceuticals has raised $670.27 thousand across 2 funding rounds. Horizon Pharmaceuticals offers products and services including BFS Manufacturing Service, Formulation Development, and Custom Container Design. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioprotection. Its legal entity is Horizon Pharmaceuticals, Inc. Its competitors include G-Con Manufacturing, Landauer and Bioscience International; 1 of its 3 listed competitors has raised funding.

Company details

Horizon Pharmaceuticals, Inc. is a company focused on the development, manufacture and life cycle management of Blow-Fill-Seal (BFS) products for the pharmaceutical, medical device, diagnostic and clinical industries.

  • Headquarters West Palm Beach, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website horizonph.com
  • Legal Name Horizon Pharmaceuticals, Inc.
Key Metrics
  • Total Equity Funding
    $670.27K (USD)

    in 2 rounds

  • Latest Funding Round
    $32.77K (USD), Seed

    Feb 2012

Products & Services of Horizon Pharmaceuticals

Horizon Pharmaceuticals offers a comprehensive portfolio of products and services, including BFS Manufacturing Service, Formulation Development, and Custom Container Design.

BFS Manufacturing Service
Aseptic Manufacturing

Offers blow-fill-seal production for pharmaceuticals and devices

Formulation Development
Drug Development

Provides research and scale-up for pharmaceutical formulations

Custom Container Design
Product Design

Creates specialized containers for medical and diagnostic use

Funding Insights of Horizon Pharmaceuticals

Horizon Pharmaceuticals has successfully raised a total of $670.27K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $32.77 thousand completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $670,272
  • Total Rounds 2
  • Last Round Seed β€” $32,772
  • First Round $637,500

    (Jun 2011)

All 2 funding rounds of Horizon Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2012$32,772Seed––
–
Jun 2011$637,500Seed––
–

Timeline of Horizon Pharmaceuticals

3 dated milestones of Horizon Pharmaceuticals across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Horizon Pharmaceuticals is founded.
  2. Funding First funding round of $638K.
  3. Funding Latest funding round, Seed, of $33K.

Competitors of Horizon Pharmaceuticals

Horizon Pharmaceuticals has 3 listed competitors in our database, 1 of them funded. They include G-Con Manufacturing, Landauer and Bioscience International.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gconbio.com2009College Station, United States$13M43
Builds and installs prefabricated, autonomous cleanrooms
landauer.com1954Glenwood, United States
Radiation monitoring and protection
biosci-intl.com1996Rockville, United States10
Manufactures air sampling equipment to detect contamination in food, pharmaceutical, and hospital environments.
Premium access

Detailed competitors of Horizon Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Horizon Pharmaceuticals

The website of Horizon Pharmaceuticals (horizonph.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▲ 8.8% vs previous month

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Horizon Pharmaceuticals (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Horizon Pharmaceuticals

Horizon Pharmaceuticals was founded in 2008 and raised its 1st funding round 3 years after it was founded.

Horizon Pharmaceuticals is headquartered in West Palm Beach, United States. It is registered at West Palm Beach, Florida, United States.

Horizon Pharmaceuticals is a funded company, having raised a total of $670.27K across 2 funding rounds to date. The company's 1st funding round was a Seed of $637.5K, raised on Jun 2011.

Horizon Pharmaceuticals, Inc. is a company focused on the development, manufacture and life cycle management of Blow-Fill-Seal (BFS) products for the pharmaceutical, medical device, diagnostic and clinical industries.

Horizon Pharmaceuticals's top competitors include G-Con Manufacturing, Landauer and Bioscience International.

Horizon Pharmaceuticals offers BFS Manufacturing Service, Formulation Development, and Custom Container Design.

Horizon Pharmaceuticals operates through Horizon Pharmaceuticals, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available